D
STAAR Surgical Company STAA
$27.97 $0.010.04% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/27/2025 03/28/2025 12/27/2024 09/27/2024 06/28/2024
Net Income -16.81M -54.21M -34.23M 9.98M 7.38M
Total Depreciation and Amortization 1.98M 2.34M 2.38M 1.76M 1.52M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 3.46M 16.74M 6.92M 10.37M 11.80M
Change in Net Operating Assets -15.87M 29.40M 25.58M -18.29M -31.11M
Cash from Operations -27.25M -5.73M 642.00K 3.82M -10.41M
Capital Expenditure -1.79M -1.47M -5.73M -6.23M -6.24M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 26.91M 36.82M -13.77M -29.01M -14.43M
Cash from Investing 25.12M 35.35M -19.50M -35.24M -20.67M
Total Debt Issued -- -- -- -- --
Total Debt Repaid 0.00 -42.00K -41.00K -42.00K -42.00K
Issuance of Common Stock 12.00K 377.00K 40.00K 1.66M 372.00K
Repurchase of Common Stock -4.55M -1.28M -109.00K 0.00 -167.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -4.54M -948.00K -110.00K 1.62M 163.00K
Foreign Exchange rate Adjustments 686.00K 286.00K -881.00K 1.04M -330.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -5.98M 28.96M -19.84M -28.77M -31.25M